Anne Greene, PhD

TU Dublin
Professor
Anne Greene leads the Pharmaceutical Regulatory Science Team (PRST) in Technological University Dublin, where she is also a senior lecturer and director of several MSc and BSc pharmaceutical programs, including the TU Dublin MSc in Pharmaceutical Validation Technology. She has supervised several students to PhD awards in areas of quality risk management, knowledge management, operational excellence, and PAT.

Prior to embarking on an academic career, Anne worked at a senior level for several years in the pharmaceutical sector in validation and technical management roles. She has a PhD in Synthetic Organic Chemistry from University College Dublin, and is currently a member of committee of the Irish Chapter of PDA. Anne is also on the Board of Directors of Regulatory Science Ireland and is chair of the Corporate Development Committee.

Related Articles

From Data to Knowledge Management: What to Consider
Features
From Data to Knowledge Management: What to Consider

Although data and knowledge are both stand-alone disciplines that need to be systematically managed, they also must have a connection. Understanding the relationship between data and knowledge management processes and how people are leveraging advances like Pharma 4.0™ combined with these processes enables quality data transition to knowledge that can help pharmaceutical companies. The authors...

Integrating Knowledge Management and Quality Risk Management
Features
Integrating Knowledge Management and Quality Risk Management

ISPE held an Expert Xchange on 18 January 2022 entitled “Risk-Based Decision Making: Advancing the Integration of Quality Risk Management (QRM) and Knowledge Management (KM).” The session included presentations and interactive exercises that generated new and useful insights into the current effectiveness of the knowledge that flows into QRM and how a knowledge map can be used to diagnose...

Organization demographics of survey respondents; n = 25, with 20 unique organizations
Online Exclusives
Knowledge Management Implementation: A Survey of the Biopharmaceutical Industry

Knowledge management (KM) has been a recognized discipline for over 20 years in other industries, although within the biopharmaceutical industry, its discussion and formal implementation have been slow to gain momentum. The topic gained regulatory significance in 2008 when the ICH guidance document Pharmaceutical Quality System: Q10 included knowledge management as a key enabler of a...